DU022ZZ
Beam Radiation Uterus to None with None, Photons >10 MeV Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | U Female Reproductive System |
| Operation | 0 Beam Radiation |
| Body Part | 2 Uterus |
| Approach | 2 Photons >10 MeV |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation for the female reproductive system directs radiation from a machine outside the body - typically a linear accelerator - through the skin and surrounding tissue to reach a tumor in the uterus, cervix, ovary, vagina, or vulva. The beams are shaped and aimed from multiple angles so they overlap at the tumor site, concentrating the dose there while spreading a lower dose across the tissue the beams pass through on the way in.
This approach is a mainstay for cervical and endometrial cancers, often given over several weeks in a series of daily sessions, and is frequently paired with brachytherapy for cervical cancer to boost the dose to the tumor bed beyond what external beams alone can safely deliver. It's also used for vaginal and vulvar cancers, and sometimes as palliative treatment to shrink a tumor causing pain, bleeding, or obstruction when cure isn't the goal.
Treatment planning involves imaging to map the tumor and surrounding organs at risk, such as the bladder and rectum, so the radiation field can be shaped to limit exposure to those structures while still covering the target with an adequate margin.
Anatomy & Axis Detail
Uterus
The uterus is a muscular pelvic organ whose body and fundus are treated with external beam radiation typically as adjuvant therapy following surgery for endometrial carcinoma, or as part of a combined regimen for cervical cancer that extends disease into the uterine corpus. Because the uterus normally shifts position with bladder and rectal filling and its size varies with prior pregnancies or fibroids, planning requires imaging close to the time of treatment to account for this mobility. External beam to the uterus is usually delivered as part of a broader pelvic field encompassing regional lymphatics rather than as an isolated target, and is frequently sequenced before or after brachytherapy to concentrate additional dose within the uterine cavity itself.
Modality Qualifier: Photons >10 MeV
Photons >10 MeV designates the high-energy megavoltage photon beams produced by linear accelerators, used for deep-seated tumors where sufficient skin-sparing and tissue penetration are needed. It sits above the lower-energy photon options in dose distribution and reach, letting treatment planners target structures well below the surface without excessive skin dose. It differs from Electrons, which deposit energy more superficially and are chosen for shallow lesions instead.
Coding & Documentation
Coding requires documentation of the specific reproductive structure treated - uterus, cervix, ovary, vagina, or vulva each has its own body part value - along with confirmation that the source was external to the body, which is what defines this root operation. The qualifier for the type of radiation modality or energy source, where captured, should also be reflected if the facility's documentation supports that level of detail.
A common assignment mistake is coding the treatment site based on the underlying cancer diagnosis rather than the actual treatment field documented by radiation oncology - a cervical cancer patient may also receive beam radiation to nodal or pelvic regions rather than the cervix as coded, so the note needs to state where the beam was actually directed. Coders should also avoid conflating a planning or simulation session with an actual treatment delivery, since only the latter supports code assignment.